Allevion Therapeutics, Inc. — Form D
Allevion Therapeutics, Inc. of IRVINE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-14. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-07-14
- Form: D
- Accession: 0001872608-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $1.0M
- Minimum investment: $1.0M
- Investors: 1
- Date of first sale: 2021-06-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-406273
Issuer
- Name: Allevion Therapeutics, Inc.
- CIK: 0001872608
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 18001 Cowan, Suite L, IRVINE, CA, 92614
- Phone: (949) 615-7488
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Jack Wang | Director | Austin, TX |
| Roy Tanaka | Director | Irvine, CA |
| Dan Dearen | Director | Irvine, CA |
| Shinya Miike | Director | Irvine, CA |
| Neal Hermanowicz | Executive Officer | Irvine, CA |
| Mahmood Razavi | Director | Irvine, CA |
| Pintoo Shah | Executive Officer | Irvine, CA |
| Randy Werneth | Director | San Diego, CA |
| Shahram Moaddeb | Director | Irvine, CA |
| Shahram Moaddeb | Executive Officer | Irvine, CA |
| Shahram Moaddeb | Promoter | Irvine, CA |
Other filings by this issuer (1)
More